Teva Pharmaceutical Industries Ltd (TEVA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.038x

Based on the latest financial reports, Teva Pharmaceutical Industries Ltd (TEVA) has a cash flow conversion efficiency ratio of 0.038x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA313.17 Million ≈ $839.59K USD) by net assets (ILA8.31 Billion ≈ $22.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Teva Pharmaceutical Industries Ltd net asset quality index to measure how much of total assets are equity-financed.

Teva Pharmaceutical Industries Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Teva Pharmaceutical Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Teva Pharmaceutical Industries Ltd (TEVA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Teva Pharmaceutical Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teva Pharmaceutical Industries Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangling Motors Corp Ltd SHE:000550	0.015x
Kestra Medical Technologies, Ltd. Common Stock NASDAQ:KMTS	-0.064x
Adriatic Metals Plc F:3FN	-0.035x
Capital Clean Energy Carriers Corp. NASDAQ:CCEC	0.040x
Nabors Industries Ltd F:NBI1	0.079x
Zensar Technologies Limited NSE:ZENSARTECH	0.134x
Heidrick & Struggles International NASDAQ:HSII	0.264x
Guangdong Macro Co Ltd SHE:000533	0.065x

Annual Cash Flow Conversion Efficiency for Teva Pharmaceutical Industries Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Teva Pharmaceutical Industries Ltd from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Teva Pharmaceutical Industries Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA7.92 Billion ≈ $21.22 Million	ILA3.10 Billion ≈ $8.31 Million	0.392x	+79.59%
2024-12-31	ILA5.72 Billion ≈ $15.34 Million	ILA1.25 Billion ≈ $3.34 Million	0.218x	+29.50%
2023-12-31	ILA8.13 Billion ≈ $21.79 Million	ILA1.37 Billion ≈ $3.67 Million	0.168x	-7.98%
2022-12-31	ILA8.69 Billion ≈ $23.30 Million	ILA1.59 Billion ≈ $4.26 Million	0.183x	+157.78%
2021-12-31	ILA11.24 Billion ≈ $30.14 Million	ILA798.00 Million ≈ $2.14 Million	0.071x	-35.44%
2020-12-31	ILA11.06 Billion ≈ $29.65 Million	ILA1.22 Billion ≈ $3.26 Million	0.110x	+207.80%
2019-12-31	ILA15.06 Billion ≈ $40.38 Million	ILA538.00 Million ≈ $1.44 Million	0.036x	-76.94%
2018-12-31	ILA15.79 Billion ≈ $42.34 Million	ILA2.45 Billion ≈ $6.56 Million	0.155x	-17.22%
2017-12-31	ILA18.75 Billion ≈ $50.25 Million	ILA3.51 Billion ≈ $9.40 Million	0.187x	+25.30%
2016-12-31	ILA34.99 Billion ≈ $93.82 Million	ILA5.22 Billion ≈ $14.01 Million	0.149x	-19.37%
2015-12-31	ILA29.93 Billion ≈ $80.23 Million	ILA5.54 Billion ≈ $14.86 Million	0.185x	-15.64%
2014-12-31	ILA23.36 Billion ≈ $62.61 Million	ILA5.13 Billion ≈ $13.75 Million	0.220x	+53.51%
2013-12-31	ILA22.64 Billion ≈ $60.69 Million	ILA3.24 Billion ≈ $8.68 Million	0.143x	-28.48%
2012-12-31	ILA22.87 Billion ≈ $61.31 Million	ILA4.57 Billion ≈ $12.26 Million	0.200x	+8.06%
2011-12-31	ILA22.34 Billion ≈ $59.90 Million	ILA4.13 Billion ≈ $11.08 Million	0.185x	-1.57%
2010-12-31	ILA22.00 Billion ≈ $58.99 Million	ILA4.14 Billion ≈ $11.09 Million	0.188x	+7.33%
2009-12-31	ILA19.26 Billion ≈ $51.63 Million	ILA3.37 Billion ≈ $9.04 Million	0.175x	-11.32%
2008-12-31	ILA16.36 Billion ≈ $43.86 Million	ILA3.23 Billion ≈ $8.66 Million	0.197x	+49.89%
2007-12-31	ILA13.76 Billion ≈ $36.89 Million	ILA1.81 Billion ≈ $4.86 Million	0.132x	-28.44%
2006-12-31	ILA11.18 Billion ≈ $29.97 Million	ILA2.06 Billion ≈ $5.52 Million	0.184x	-18.68%
2005-12-31	ILA6.05 Billion ≈ $16.22 Million	ILA1.37 Billion ≈ $3.67 Million	0.226x	-2.09%
2004-12-31	ILA5.40 Billion ≈ $14.48 Million	ILA1.25 Billion ≈ $3.35 Million	0.231x	+21.65%
2003-12-31	ILA3.30 Billion ≈ $8.84 Million	ILA626.60 Million ≈ $1.68 Million	0.190x	-1.41%
2002-12-31	ILA1.83 Billion ≈ $4.92 Million	ILA353.70 Million ≈ $948.26K	0.193x	-2.38%
2001-12-31	ILA1.38 Billion ≈ $3.71 Million	ILA273.15 Million ≈ $732.30K	0.198x	+37.51%
2000-12-31	ILA1.15 Billion ≈ $3.09 Million	ILA165.63 Million ≈ $444.04K	0.144x	-30.58%
1999-12-31	ILA742.30 Million ≈ $1.99 Million	ILA153.61 Million ≈ $411.82K	0.207x	+94.44%
1998-12-31	ILA659.60 Million ≈ $1.77 Million	ILA70.20 Million ≈ $188.20K	0.106x	-66.31%
1997-12-31	ILA612.80 Million ≈ $1.64 Million	ILA193.60 Million ≈ $519.03K	0.316x	+2586.53%
1996-12-31	ILA535.20 Million ≈ $1.43 Million	ILA-6.80 Million ≈ $-18.23K	-0.013x	-104.91%
1995-12-31	ILA407.60 Million ≈ $1.09 Million	ILA105.40 Million ≈ $282.57K	0.259x	+131.78%
1994-12-31	ILA342.40 Million ≈ $917.96K	ILA38.20 Million ≈ $102.41K	0.112x	-20.72%
1993-12-31	ILA267.90 Million ≈ $718.23K	ILA37.70 Million ≈ $101.07K	0.141x	+11.33%
1992-12-31	ILA223.10 Million ≈ $598.12K	ILA28.20 Million ≈ $75.60K	0.126x	+154.19%
1991-12-31	ILA183.00 Million ≈ $490.62K	ILA9.10 Million ≈ $24.40K	0.050x	--

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$32.44 Billion

ILA12.10 Trillion ILA

Market Cap Rank

#8049 Global

#69 in Israel

Share Price

ILA10390.00

Change (1 day)

-0.38%

52-Week Range

ILA5600.00 - ILA11350.00

All Time High

ILA25447.60